Modern antiretroviral therapy (ART) regimens are among the greatest successes of modern. medicine and have shifted the prognosis of HIV-infected patients from years to decades. Despite that †œgraying†� of the HIV-infected population is a huge clinical success, ART has failed in its attempt to completely restore normal health. The aim of this work is to establish the impact of MRV on co-morbidities and his relationship with the variation f immunological markers such as CD4 nadir, CD4/CD8 and CD8+CD38+.
The impact of MRV on HIV co-morbidities
2017
Abstract
Modern antiretroviral therapy (ART) regimens are among the greatest successes of modern. medicine and have shifted the prognosis of HIV-infected patients from years to decades. Despite that †œgraying†� of the HIV-infected population is a huge clinical success, ART has failed in its attempt to completely restore normal health. The aim of this work is to establish the impact of MRV on co-morbidities and his relationship with the variation f immunological markers such as CD4 nadir, CD4/CD8 and CD8+CD38+.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
TESI_VERSIONE_FINALE.pdf
accesso solo da BNCF e BNCR
Tipologia:
Altro materiale allegato
Licenza:
Tutti i diritti riservati
Dimensione
1.9 MB
Formato
Adobe PDF
|
1.9 MB | Adobe PDF |
I documenti in UNITESI sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
Utilizza questo identificativo per citare o creare un link a questo documento:
https://hdl.handle.net/20.500.14242/306269
Il codice NBN di questa tesi è
URN:NBN:IT:UNIMORE-306269